Michael Rawlins, Medicines and Healthcare Products Regulatory Agency, UK
Sir Michael Rawlins is a physician and a scientist who, from 1973–2006, was a professor of clinical pharmacology and a general physician at Newcastle University. During this period, he also did several national activities, including chairman of the Committee on the Safety of Medicines (1992–98), chairman of the Advisory Council on the Misuse of Drugs (1998–2008), and chairman of the National Institute for Clinical Excellence (1999–2013). Sir Rawlins demitted as chair of the National Institute for Health and Care Excellence at the end of March, 2013. He was president of the Royal Society of Medicine (2012–14) and chairman of the UK Biobank (2010–11). From Dec 1, 2014, he has been chair of the Medicines and Healthcare products Regulatory Agency and was reappointed in 2017 until Nov 30, 2020. He also chaired the Department of Health’s Regenerative Medicine and Cell Therapy Expert Group and National Health Service England’s Clinical Advisory Panel for Congenital Heart Disease.
« Go Back